Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 52 min 22 sec ago

Jakavi(R) (ruxolitinib) Receives European Commission Approval as First Targeted Therapy for Patients with Polycythemia Vera

Tue, 03/17/2015 - 13:21
WILMINGTON, Del.--(Healthcare Sales & Marketing Network)--Incyte Corporation (Nasdaq: INCY) announced today that Novartis received approval from the European Commission for Jakavi® (ruxolitinib) for the treatment of adult patients with polycythemia ver...
Biopharmaceuticals, Oncology, Regulatory
Incyte, Jakavi, Jakafi, ruxolitinib, polycythemia vera

Vascular Solutions Launches PolarCath(TM) Peripheral Dilatation System

Mon, 03/16/2015 - 21:31
MINNEAPOLIS, March 16, 2015 -- (Healthcare Sales & Marketing Network) -- Vascular Solutions, Inc. (VASC) today announced that it has commenced sales of the PolarCath peripheral dilatation system in the United States in collaboration with NuCryo Vascular LL...
Devices, Interventional, Product Launch
Vascular Solutions, NuCryo Vascular, PolarCath, peripheral dilatation

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong